| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Maria C Rotolo, Silvia Graziano, Manuela Pellegrini, Daniele Corlazzoli, Lucia Antinori, Laura Porcarelli, Simona Pichin. Simple and Fast Gas-chromatography Mass Spectrometry Assay to Assess Delta 9-Tetrahydrocannabinol and Cannabidiol in Dogs Treated with Medical Cannabis for Canine Epilepsy. Current pharmaceutical biotechnology. vol 18. issue 10. 2018-05-29. PMID:29173160. |
simple and fast gas-chromatography mass spectrometry assay to assess delta 9-tetrahydrocannabinol and cannabidiol in dogs treated with medical cannabis for canine epilepsy. |
2018-05-29 |
2023-08-13 |
dog |
| Orrin Devinsky, Anup D Patel, J Helen Cross, Vicente Villanueva, Elaine C Wirrell, Michael Privitera, Sam M Greenwood, Claire Roberts, Daniel Checketts, Kevan E VanLandingham, Sameer M Zuber. Effect of Cannabidiol on Drop Seizures in the Lennox-Gastaut Syndrome. The New England journal of medicine. vol 378. issue 20. 2018-05-24. PMID:29768152. |
cannabidiol has been used for treatment-resistant seizures in patients with severe early-onset epilepsy. |
2018-05-24 |
2023-08-13 |
Not clear |
| Luciano R Vilela, Isabel V Lima, Érica B Kunsch, Hyorrana Priscila P Pinto, Aline S de Miranda, Érica Leandro M Vieira, Antônio Carlos P de Oliveira, Marcio Flávio D Moraes, Antônio L Teixeira, Fabricio A Moreir. Anticonvulsant effect of cannabidiol in the pentylenetetrazole model: Pharmacological mechanisms, electroencephalographic profile, and brain cytokine levels. Epilepsy & behavior : E&B. vol 75. 2018-04-27. PMID:28821005. |
cannabidiol (cbd), the main nonpsychotomimetic compound from cannabis sativa, inhibits experimental seizures in animal models and alleviates certain types of intractable epilepsies in patients. |
2018-04-27 |
2023-08-13 |
Not clear |
| Gábor Nagy-Grócz, Ferenc Zádor, Szabolcs Dvorácskó, Zsuzsanna Bohár, Sándor Benyhe, Csaba Tömböly, Árpád Párdutz, László Vécse. Interactions between the Kynurenine and the Endocannabinoid System with Special Emphasis on Migraine. International journal of molecular sciences. vol 18. issue 8. 2018-04-17. PMID:28758944. |
the interaction of the endocannabinoid and kynurenine system has been demonstrated to be therapeutically relevant in a number of pathological conditions, such as cannabis addiction, psychosis, schizophrenia and epilepsy. |
2018-04-17 |
2023-08-13 |
Not clear |
| Brian D Klein, Catherine A Jacobson, Cameron S Metcalf, Misty D Smith, Karen S Wilcox, Aidan J Hampson, John H Kehn. Evaluation of Cannabidiol in Animal Seizure Models by the Epilepsy Therapy Screening Program (ETSP). Neurochemical research. vol 42. issue 7. 2018-04-16. PMID:28478594. |
evaluation of cannabidiol in animal seizure models by the epilepsy therapy screening program (etsp). |
2018-04-16 |
2023-08-13 |
mouse |
| Maria Chiara Paolino, Alessandro Ferretti, Laura Papetti, Maria Pia Villa, Pasquale Paris. Cannabidiol as potential treatment in refractory pediatric epilepsy. Expert review of neurotherapeutics. vol 16. issue 1. 2018-04-10. PMID:26567560. |
cannabidiol as potential treatment in refractory pediatric epilepsy. |
2018-04-10 |
2023-08-13 |
Not clear |
| Maria Chiara Paolino, Alessandro Ferretti, Laura Papetti, Maria Pia Villa, Pasquale Paris. Cannabidiol as potential treatment in refractory pediatric epilepsy. Expert review of neurotherapeutics. vol 16. issue 1. 2018-04-10. PMID:26567560. |
in recent years there has been great scientific and public interest focused on the therapeutic potential of compounds derived from cannabis for the treatment of refractory epilepsy in children. |
2018-04-10 |
2023-08-13 |
Not clear |
| Basanagoud Mudigoudar, Sarah Weatherspoon, James W Wheles. Emerging Antiepileptic Drugs for Severe Pediatric Epilepsies. Seminars in pediatric neurology. vol 23. issue 2. 2018-01-26. PMID:27544474. |
this article reports the clinical trial data and personal experience in treating the severe epilepsies of childhood with the recently food and drug administration-approved new antiepileptic drugs (vigabatrin, rufinamide, perampanel, and clobazam) and those in clinical trials (cannabidiol, stiripentol, and fenfluramine). |
2018-01-26 |
2023-08-13 |
Not clear |
| Ethan B Russ. Cannabis and epilepsy: An ancient treatment returns to the fore. Epilepsy & behavior : E&B. vol 70. issue Pt B. 2018-01-16. PMID:27989385. |
cannabis and epilepsy: an ancient treatment returns to the fore. |
2018-01-16 |
2023-08-13 |
Not clear |
| Ethan B Russ. Cannabis and epilepsy: An ancient treatment returns to the fore. Epilepsy & behavior : E&B. vol 70. issue Pt B. 2018-01-16. PMID:27989385. |
cannabis has been associated with the treatment of epilepsy throughout history, and if ancient assyrian sources referring to "hand of ghost" are considered credible, this relationship may span four millennia. |
2018-01-16 |
2023-08-13 |
Not clear |
| Ethan B Russ. Cannabis and epilepsy: An ancient treatment returns to the fore. Epilepsy & behavior : E&B. vol 70. issue Pt B. 2018-01-16. PMID:27989385. |
resumption of research coupled with mass experimentation by families of epilepsy patients has led to intense interest in cannabis-based medicines for its treatment once more, with greatest focus on cannabidiol, but additional investigation of tetrahydrocannabinol, tetrahydrocannabinolic acid, and other phytocannabinoids. |
2018-01-16 |
2023-08-13 |
Not clear |
| Tyler E Gaston, Daniel Friedma. Pharmacology of cannabinoids in the treatment of epilepsy. Epilepsy & behavior : E&B. vol 70. issue Pt B. 2018-01-16. PMID:28087250. |
the use of cannabis products in the treatment of epilepsy has long been of interest to researchers and clinicians alike; however, until recently very little published data were available to support its use. |
2018-01-16 |
2023-08-13 |
human |
| Daniel Friedman, Joseph I Sirve. Historical perspective on the medical use of cannabis for epilepsy: Ancient times to the 1980s. Epilepsy & behavior : E&B. vol 70. issue Pt B. 2018-01-16. PMID:28089286. |
historical perspective on the medical use of cannabis for epilepsy: ancient times to the 1980s. |
2018-01-16 |
2023-08-13 |
Not clear |
| Daniel Friedman, Joseph I Sirve. Historical perspective on the medical use of cannabis for epilepsy: Ancient times to the 1980s. Epilepsy & behavior : E&B. vol 70. issue Pt B. 2018-01-16. PMID:28089286. |
there has been a dramatic surge in the interest of utilizing cannabis for epilepsy treatment in the us. |
2018-01-16 |
2023-08-13 |
Not clear |
| Daniel Friedman, Joseph I Sirve. Historical perspective on the medical use of cannabis for epilepsy: Ancient times to the 1980s. Epilepsy & behavior : E&B. vol 70. issue Pt B. 2018-01-16. PMID:28089286. |
from ancient chinese pharmacopeias to the current phase iii trials of pharmaceutical grade cannabidiol, this review covers the time span of cannabis use for epilepsy therapy so as to better assess the issues surrounding the modern medical opinion of cannabis use. |
2018-01-16 |
2023-08-13 |
Not clear |
| Jane B Allendorfer, Jerzy P Szaflarsk. Neuroimaging studies towards understanding the central effects of pharmacological cannabis products on patients with epilepsy. Epilepsy & behavior : E&B. vol 70. issue Pt B. 2018-01-16. PMID:28109780. |
neuroimaging studies towards understanding the central effects of pharmacological cannabis products on patients with epilepsy. |
2018-01-16 |
2023-08-13 |
Not clear |
| Jane B Allendorfer, Jerzy P Szaflarsk. Neuroimaging studies towards understanding the central effects of pharmacological cannabis products on patients with epilepsy. Epilepsy & behavior : E&B. vol 70. issue Pt B. 2018-01-16. PMID:28109780. |
therefore, this review focuses only on the functional mri studies investigating the effects of specific pharmacological preparations of cannabis compounds, specifically thc, tetrahydrocannabivarin (thcv), and cbd, on brain function in healthy individuals and persons with epilepsy with references to non-epilepsy studies only to underline the gaps in research that need to be filled before cannabis-derived products are considered for a wide use in the treatment of epilepsy. |
2018-01-16 |
2023-08-13 |
Not clear |
| Magdalena Szaflarski, Joseph I Sirve. Social factors in marijuana use for medical and recreational purposes. Epilepsy & behavior : E&B. vol 70. issue Pt B. 2018-01-16. PMID:28132734. |
in order to best understand how to approach this controversial treatment, it is essential to explore the social, demographic, and historical variables that have led to the current opinions on cannabis therapy and how this has converged on epilepsy treatment. |
2018-01-16 |
2023-08-13 |
Not clear |
| Magdalena Szaflarski, Joseph I Sirve. Social factors in marijuana use for medical and recreational purposes. Epilepsy & behavior : E&B. vol 70. issue Pt B. 2018-01-16. PMID:28132734. |
utilizing a sociological conceptual framework, this review discusses in depth the social, cultural, and historical dimensions of cannabis use in the us for medical purposes and its impact on epilepsy treatment. |
2018-01-16 |
2023-08-13 |
Not clear |
| Brooke K O'Connell, David Gloss, Orrin Devinsk. Cannabinoids in treatment-resistant epilepsy: A review. Epilepsy & behavior : E&B. vol 70. issue Pt B. 2018-01-16. PMID:28188044. |
cannabis-based therapies have been used to treat epilepsy for millennia, but only in the last few years have we begun to collect data from adequately powered placebo-controlled, randomized trials (rcts) with cannabidiol (cbd), a cannabis derivative. |
2018-01-16 |
2023-08-13 |
Not clear |